Authors: EGILMAN DS HOM CM

Citation: Ds. Egilman et Cm. Hom, CORRUPTION OF THE MEDICAL LITERATURE - A 2ND VISIT, American journal of industrial medicine, 34(4), 1998, pp. 401-404

Authors: EGILMAN DS GOLDIN AS GOLDIN GA

Citation: Ds. Egilman et al., MESOTHELIOMA - AN UNWARRANTED CAUSAL MODEL, Journal of occupational and environmental medicine, 38(3), 1996, pp. 239-240

Authors: EGILMAN DS STUBBS C

Citation: Ds. Egilman et C. Stubbs, EVALUATING THE HEALTH RISKS OF BREAST IMPLANTS, The New England journal of medicine, 335(15), 1996, pp. 1154-1155

Authors: EGILMAN DS REINERT AA

Citation: Ds. Egilman et Aa. Reinert, THE ORIGIN AND DEVELOPMENT OF THE ASBESTOS THRESHOLD LIMIT VALUE - SCIENTIFIC INDIFFERENCE AND CORPORATE INFLUENCE, International journal of health services, 25(4), 1995, pp. 667-696

Authors: DURAND KTH EGILMAN DS

Citation: Kth. Durand et Ds. Egilman, THE DUPONT IMRON(R) STUDIES - AN EXAMPLE OF POSSIBLE MISREPRESENTATION OF DATA IN THE INDUSTRIAL-HYGIENE LITERATURE, American Industrial Hygiene Association journal, 56(8), 1995, pp. 817-825

Authors: EGILMAN DS HARDY HL

Citation: Ds. Egilman et Hl. Hardy, MANIPULATION OF EARLY ANIMAL RESEARCH ON ASBESTOS CANCER, American journal of industrial medicine, 24(6), 1993, pp. 787-791